Stay updated on G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2; no changes to the study details, eligibility criteria, or outcomes are evident on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the government funding and operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo significant changes detected in the Study Details page for NCT03455270; the study design, eligibility criteria, locations, and outcomes remain unchanged.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference4%

- Check78 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated to v3.0.2 and the Back to Top link was removed; no changes to core content, pricing, stock, or date/time information.SummaryDifference0.2%

Stay in the know with updates to G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.